Lymphoma clinical trials in New Jersey
12 active Lymphoma trials with a site in New Jersey. Describe your situation to see which ones look like a fit.
- First in Human, Dose Escalation Study of AN4005
- A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
- A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Mosaic Trial for Stem Cell Transplant Recipients
- Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Rutgers University Study of the Genetics of Blood Cancers
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.